- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03203720
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder (BMI)
February 2, 2021 updated by: Tina R Goldstein, University of Pittsburgh
Adolescence is the peak onset period for serious and persistent psychiatric disorders.
Treatment guidelines for management of major psychiatric disorders in youth include pharmacotherapy.
There has been substantial progress in recent years in identifying effective medications for youth with psychiatric disorders.
However, adherence to prescribed medications among psychiatric populations is notoriously low, and adolescents rank among the least adherent of all patient populations.
Given that the consequences of poor medication adherence among youth with chronic mental illness are far-reaching, including hospitalization, poor functioning, and suicide, there is a desperate need for interventions targeting medication adherence in this population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Adolescence is the peak period of onset for serious and persistent psychiatric disorders.
Treatment guidelines for the management of major psychiatric disorders in adolescence indicate pharmacotherapy is a critical element of effective treatment.
Unfortunately, adolescence is a particularly vulnerable window for poor medication adherence, and little is known about the timecourse and specific factors associated with poor medication adherence in this population.
Given that the consequences of poor medication adherence among youth with chronic mental illness are far-reaching, and include hospitalization, profound functional impairment and even suicide, there is a desperate need for interventions targeting medication adherence in this population.
Motivational Interviewing (MI) is an evidence-based approach focused on enhancing motivation for change.
This model holds great promise for improving medication adherence in adolescents with psychiatric disorders because it is developmentally sensitive, acceptable to patients and providers, and readily disseminable across clinical settings.
Research demonstrates that brief motivational interventions (BMIs) utilizing a MI approach result in improved treatment adherence among youth with a variety of chronic medical conditions.
Although widely applied for adolescent substance use behaviors, BMIs have yet to be examined for improving medication adherence in youth with severe psychiatric disorders.
Adolescents with bipolar disorder (BP) are an ideal population with whom to develop a BMI for medication adherence because adolescents with BP are among the least adherent of any psychiatric population.
Experience developing a BMI for this challenging population will directly inform intervention for youth with a range of chronic psychiatric disorders.
The purpose of the proposed study is to conduct a small randomized trial comparing CABS Standard Care (SC) augmented with the BMI versus SC alone.
Outcomes will be assessed monthly over 6 months.
Participants will include 40 adolescents with BP.
This approach is in direct accord with the National Institute of Mental Health (NIMH) Strategic Plan in which the development and testing of innovative interventions to reduce risk and positively alter trajectories of mental illness are informed by research findings regarding robust and malleable risk factors.
Research in this area is of great public health importance, as it has the potential to lessen costs, disrupt the cycle of poor outcomes, and minimize the long-term debilitating effects of these serious disorders.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Western Psychiatric Institute and Clinic / University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 22 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 12 years, 0 months to 22 years, 11 months;
- a diagnosis of BP spectrum disorder via semi-structured interview;
- willing to engage in treatment at the BP specialty clinic;
- English fluency and understanding, as the study consists of interviews and surveys that necessitate English fluency and understanding;
- able and willing to give informed consent/assent to participate.
Exclusion Criteria:
- evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder by semi-structured interview, parent report, medical history, or school records;
- a life-threatening medical condition requiring immediate treatment;
- current victim of sexual or physical abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard Care (SC)
Standard Care (SC) in a specialty mood disorders clinic for youth with mood disorders.
|
|
Experimental: SC + Brief Motivational Intervention
Standard Care (SC) in a specialty mood disorders clinic plus a Brief Motivational Intervention (BMI) targeting medication adherence.
|
A brief motivational intervention centered around Motivational Interviewing (MI) techniques.
Sessions are adjunct to standard clinical care, and focus on psychoeducation regarding treatment for bipolar disorder, and resolving ambivalence regarding taking medications for mood disorder.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective Medication Adherence
Time Frame: 6 months
|
Medication adherence via electronic pillbox
|
6 months
|
Subjective Medication Adherence
Time Frame: 6 months
|
Self-reported medication adherence
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mood disorder symptoms
Time Frame: Quarterly over 6 months
|
Depressive and manic symptoms as measured via semi-structured interview
|
Quarterly over 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 11, 2011
Primary Completion (Actual)
December 30, 2014
Study Completion (Actual)
December 30, 2014
Study Registration Dates
First Submitted
June 23, 2017
First Submitted That Met QC Criteria
June 26, 2017
First Posted (Actual)
June 29, 2017
Study Record Updates
Last Update Posted (Actual)
February 3, 2021
Last Update Submitted That Met QC Criteria
February 2, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH092424
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Centre for Addiction and Mental HealthUniversity Health Network, TorontoNot yet recruitingBipolar Disorder | Bipolar Depression | Treatment- Resistant Bipolar Disorder | Type 2 Bipolar DisorderCanada
Clinical Trials on Brief Motivational Intervention
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | HIV | Drug UseUnited States
-
Centers for Disease Control and PreventionUnknownAccidents, Traffic
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)CompletedHIV Infections | Hepatitis B | Hepatitis C | HIV | Substance Abuse Detection | Brief InterventionUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
University of CalgaryCompleted
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Marijuana Use | Alcohol Consumption | Unsafe Sex
-
Brigham and Women's HospitalCompletedMotivational Interviewing | Advance Care Planning | Emergency Service, HospitalUnited States
-
Centers for Disease Control and PreventionTulane University School of Public Health and Tropical MedicineSuspendedBacterial Vaginosis | Vaginal DouchingUnited States
-
University of ExtremaduraCompleted
-
University of Missouri-ColumbiaCompletedPhysical Inactivity | Poor DietUnited States